Navigation Links
Hospira Announces New Contracts With Premier Purchasing Partners for Infusion Devices, Solutions And Equipment
Date:8/21/2008

LAKE FOREST, Ill., Aug. 21 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a global specialty pharmaceutical and medication delivery company, today announced new national agreements with Premier Purchasing Partners. The multi-year contracts will provide Premier's 2,000 member hospitals with access to special pricing and terms pre-negotiated by Premier for Hospira's general-purpose medication infusion devices, related sets and disposables, along with intravenous (I.V.) solutions, nutritionals, drug-delivery and gravity administration sets. The five-year Premier agreements will be effective February 1, 2009.

"Premier shares our commitment to improving patient and caregiver safety, while reducing the high costs of healthcare," said Pete Baker, vice president and general manager, Commercial Service Operations, Hospira. "Hospira products and services are well positioned to deliver positive results in these critical areas for the Premier membership. We look forward to collaborating with Premier's member healthcare institutions to provide innovative solutions and drive results."

The new agreements include Hospira's general-purpose medication management technologies, such as the Plum A+(R) and next-generation Symbiq(R) infusion systems with Hospira MedNet(R) safety software; and pain management pumps, such as LifeCare PCA(R) with Hospira MedNet and GemStar(R) ambulatory devices. These products play a critical role in improving patient safety as well as enhancing quality of care and clinician workflow. Also covered within the agreement is access to contracts for Hospira's I.V. solutions and associated equipment portfolio, including the company's environmentally preferable VisIV(R) container. This represents the first opportunity for Hospira to offer these full product lines to Premier member healthcare institutions on contract.

About Premier Inc., 2006 Malcolm Baldrige National Quality Award recipient

Serving more than 2,000 U.S. hospitals and 53,000-plus other healthcare sites, the Premier healthcare alliance and its members are transforming healthcare together. Owned by not-for-profit hospitals, Premier operates one of the leading healthcare purchasing networks and the nation's most comprehensive repository of hospital clinical and financial information. A subsidiary operates one of the nation's largest policy-holder owned, hospital professional liability risk-retention groups. A world leader in helping healthcare providers deliver dramatic improvements in care, Premier is working with the United Kingdom's National Health Service North West and the Centers for Medicare & Medicaid Services to improve hospital performance. Headquartered in San Diego, Premier has offices in Charlotte, N.C., Philadelphia and Washington. For more information, visit http://www.premierinc.com.

About Hospira

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness(TM). As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has more than 14,000 employees. Learn more at http://www.hospira.com.


'/>"/>
SOURCE Hospira, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Hospira Reports Second-Quarter 2008 Results
2. Hospira Hosts Conference Call for Second-Quarter 2008 Earnings
3. Hospira Highlights Strategic Initiatives at Its 2008 Annual Meeting of Shareholders
4. Hospira to Present at the Bank of America 2008 Health Care Conference on May 14
5. Hospira Acquires Sculptor
6. Hospira Hosts Conference Call for First-Quarter 2008 Earnings
7. Hospira to Present at the Bear Stearns 10th Annual London Healthcare Conference on March 13
8. Hospira Reports Fourth-Quarter and Full-Year 2007 Results
9. Hospira Launches Generic Irinotecan Injection
10. Hospira Announces New Contract With HealthTrust Purchasing Group for Infusion Devices, Solutions and Equipment
11. Hospira Hosts Conference Call for Fourth-Quarter 2007 Results and 2008 Projections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... 24, 2017 , ... “End Time GPS”: a dauntless and enlightened study ... Time GPS” is the creation of published author, Wesley Gerboth, a World War II ... and space-vehicle projects. Now, at age ninety-one, he shares the Wisdom God bestowed upon ...
(Date:3/24/2017)... ... , ... “The Communion of Saints: A Pastor’s Potpourri of ... across the United States. “The Communion of Saints” is the creation of ... congregations in seven states throughout his long career of devotion to the church. ...
(Date:3/23/2017)... ... March 23, 2017 , ... In 2016 the World ... that there could be four million Zika-related cases in the Americas within the next ... of US cases reported per year skyrocketing to an estimated 329,000. Yet, Zika, Lyme ...
(Date:3/23/2017)... , ... March 23, 2017 , ... The physicians of ... in the greater Houston Area. The new location is located at 2255 E. Mossy ... in Springwoods Village. This newest location will provide patients living in the north Houston ...
(Date:3/23/2017)... New Braunfels, TX (PRWEB) , ... March 23, 2017 , ... ... a new clinic, located at 960 Gruene Road in Building 2. The clinic is ... co-owner Dr. Andrew Bennett, PT, says opening the company’s second New Braunfels location brings ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... Research and Markets has announced the addition of the "Dental Implants ... ... for Dental Implants in US$ Million. The report provides separate comprehensive analytics ... , Europe , Asia-Pacific , ... Annual estimates and forecasts are provided for the period 2015 through 2022. ...
(Date:3/24/2017)... , March 24, 2017 FinancialBuzz.com News ... ... publisher of cannabis market research, the legal cannabis market is ... through 2021, despite conflicting signals from the current presidential administration. ... that the two biggest drivers of growth in this industry ...
(Date:3/24/2017)... Research and Markets has announced the addition of the "Deep ... to their offering. ... The Deep Learning: Drug Discovery and Diagnostics Market, 2017-2035 report examines ... deep learning solutions within the healthcare domain. Primarily driven by the ... solution to generate relevant insights from medical data. ...
Breaking Medicine Technology: